Biologics and Biosimilars as Treatment Options for Psoriasis
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.
| Egile nagusia: | Moya, Amena Khatun |
|---|---|
| Beste egile batzuk: | Kabir, Dr. Eva Rahman |
| Formatua: | Thesis |
| Hizkuntza: | en_US |
| Argitaratua: |
Brac University
2023
|
| Gaiak: | |
| Sarrera elektronikoa: | http://hdl.handle.net/10361/17712 |
Antzeko izenburuak
-
Pharmacokinetics, safety, efficacy and immunogenicity of Adalimumab biosimilar ABP-501in rheumatoid arthritis and plaque psoriasis
nork: Akter, Anika
Argitaratua: (2022) -
A pharmacovigilance study on FDA approved interleukin inhibitor-associated alopecia in the treatment of psoriasis
nork: Islam, Nahidul
Argitaratua: (2023) -
Detection of skin diseases using deep learning
nork: Shodoy, Masuk Ur Rahman
Argitaratua: (2024) -
Biosimilar in lymphoma treatment
nork: Tanisha, Mehrin Haque
Argitaratua: (2021) -
Biosimilar insulins: a potential option in the treatment of Diabetes
nork: Tabassum, Turana
Argitaratua: (2022)